NH

Norbert Heimburger

BE Behringwerke: 27 patents #1 of 317Top 1%
AG Aventis Behring Gmbh: 3 patents #11 of 87Top 15%
DG Dade Behring Marburg Gmbh: 1 patents #88 of 190Top 50%
Hoechst Gmbh: 1 patents #2,248 of 4,020Top 60%
Overall (All Time): #114,405 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 25 most recent of 32 patents

Patent #TitleCo-InventorsDate
6500427 One-component tissue adhesive and a process for the production thereof Peter Fuhge, Hansjorg Ronneberger 2002-12-31
6346277 Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X Gerhardt Kumpe, Wilfried Wormsbacher, Hans M. Preis 2002-02-12
6239261 Pasteurized, purified von Willebrand factor concentrate and a process for the preparation thereof Gerhard Kumpe, Klaus Wellner 2001-05-29
6048684 "Method for the determination of ""soluble"" fibrin" Udo Becker, Konrad Braun 2000-04-11
5695753 Transglutaminases as immunosuppressants Thomas Stief, Hans-Ulrich Schorlemmer 1997-12-09
5607837 Method for the determination of the plasminogen activator activity in samples containing alpha-2-antiplasmin Thomas Stief 1997-03-04
5512449 Method for the functional determination of protein C inhibitor Thomas Stief, Klaus-Peter Radtke 1996-04-30
5464615 Use of transglutaminases as immunosuppressants Thomas Stief, Hans-Ulrich Schorlemmer 1995-11-07
5424401 Process for the preparation of a stable factor VIII Klaus Wellner, Karl-Heinz Wenz, Gerhardt Kumpe 1995-06-13
5407671 One-component tissue adhesive and a process for the production thereof Peter Fuhge, Hansjorg Ronneberger 1995-04-18
5204256 Process for the purification of plasminogen activator inhibitor 2 (PAI-2) Klaus-Peter Radtke, Karlheinz Wenz 1993-04-20
5136026 Process for removing toxins from protein solutions Jürgen Römisch 1992-08-04
5091363 Agent for the therapy of factor VIII-resistant hemophilia A, and a process for the preparation thereof Karlheinz Wenz, Wilfried Wormsbacher 1992-02-25
5057414 Method for the determination of the activity of serine proteases or serine protease inhibitors Thomas Stief 1991-10-15
5049545 Insulin derivatives, a process for their preparation, and their use Hartmut Lobermann, Eric-Paul Paques 1991-09-17
5043428 Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production Wilfried Wormsbacher, Gerhardt Kumpe 1991-08-27
5021243 Process for the preparation of factor VIII:C-deficient plasma, and a deficient plasma obtained in this way Udo Becker, Konrad Braun 1991-06-04
4960757 Pasteurized human fibrinogen (HF), a process for its preparation, and its use Gerhardt Kumpe, Wilfried Wormsbacher, Peter Fuhge, Hans M. Preis 1990-10-02
4915945 Process for the preparation of the C1 inactivator Hermann Pelzer, Helmut Heber, Hans M. Preis, Horst Naumann 1990-04-10
4670544 Process for the manufacture of the cold insoluble globulin and pharmaceutical preparation containing it Horst Schwinn, Gerhard Kumpe, Bernd Herchenhan 1987-06-02
4650678 Readily dissolvable lyophilized fibrinogen formulation Peter Fuhge, Hans-Arnold Stohr, Wolfgang Burk 1987-03-17
4579735 Process for the pasteurization of human residual plasma Hermann E. Karges, Gerhardt Kumpe, Wilfried Wormsbacher 1986-04-01
4562072 Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby Gerhardt Kumpe, Wilfried Wormsbacher, Hans M. Preis 1985-12-31
4442213 Process for the preparation of plasminogen and plasminogen thus prepared Helmut Heber, Horst Schwinn, Gerhardt Kumpe, Manfred Schick 1984-04-10
4411794 Process for the purification of the blood clotting factors, II, VII, IX and/or X Horst Schwinn, Gerhardt Kumpe, Heinz-Hermann Drescher 1983-10-25